Thus, blockage of the bFGF/FGFR3/RSK2 signaling axis by kaempferol may inhibit the progressive structural damage of RA joints that is induced by overwhelming osteoclast activity. The gene discussed is RPS6KA3; the disease is rheumatoid arthritis.